Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency

Yaomei Wang, Wei Li, Vincent P. Schulz, Huizhi Zhao, Xiaoli Qu, Qian Qi, Yong Cheng, Xinhua Guo, Shijie Zhang, Xin Wei, Donghao Liu, Karina Yazdanbakhsh, Christopher D. Hillyer, Narla Mohandas, Lixiang Chen, Patrick G. Gallagher, Xiuli An

Blood (2021) 138 (17): 1615–1627.

https://doi.org/10.1182/blood.2020007401

Published: 2021

Includes: Supplemental data

Journal Articles

Leveraging gene expression subgroups to classify DLBCL patients and select for clinical benefit from a novel agent

Alberto Risueño, Patrick R. Hagner, Fadi Towfic, Celia Fontanillo, Amira Djebbari, Joel S. Parker, Clifton P. Drew, Grzegorz S. Nowakowski, Matthew J. Maurer, James R. Cerhan, Xin Wei, Yan Ren, Chung-Wein Lee, Suzana Couto, Maria Wang, Michael Pourdehnad, Anita K. Gandhi, Matthew W. B. Trotter

Blood (2020) 135 (13): 1008–1018.

https://doi.org/10.1182/blood.2019002414

Published: 2020

Includes: Supplemental data

Journal Articles

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

Blood (2020) 135 (13): 996–1007.

https://doi.org/10.1182/blood.2019002395

Published: 2020

Includes: Supplemental data

Journal Articles

Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)

Pau Abrisqueta, MD PhD, Juan-Manuel Sancho, MD PhD, Raul Cordoba, MD PhD, Daniel O. Persky, MD, Charalambos Andreadis, MD MSCE, Scott F. Huntington, MD MPH, Cecilia Carpio, MD, Daniel Morillo Giles, MD, Xin Wei, PhD, Ying Fei Li, PhD, Marlene Zuraek, MD, Michael R. Burgess, Kristen Hege, Alejandro Martín, MD PhD

Blood (2019) 134 (Supplement_1): 4089.

https://doi.org/10.1182/blood-2019-125310

Published: 2019

Journal Articles

A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results

Amer M. Zeidan, MBBS, MHS, Daniel J. DeAngelo, MD PhD, Jeanne M. Palmer, Christopher S. Seet, MD PhD, Martin S. Tallman, MD, Xin Wei, PhD, Ying Fei Li, PhD, Nanette Hock, RN, MSN, Michael R. Burgess, Kristen Hege, Wendy Stock, MD

Blood (2019) 134 (Supplement_1): 1320.

https://doi.org/10.1182/blood-2019-125363

Published: 2019

Journal Articles

Costs and in-Hospital Mortality Rates in Autologous Stem Cell Transplant for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample (NIS) Database

Yuzhou Liu, MD, Hedong Han, MD, Xin Wei, MD, Qian Wang, MD MPH, Jia He, MD PhD, Gunjan L. Shah, MD, Sergio A. Giralt, MD, Ola Landgren, MD PhD, Alexander Lesokhin, MD

Blood (2017) 130 (Supplement 1): 2108.

https://doi.org/10.1182/blood.V130.Suppl_1.2108.2108

Published: 2017

Journal Articles

Outcomes of Early Plasmapheresis Vs Late Plasmapheresis in Patients with Thrombocytopenic Thrombotic Purpura: A Nationwide Analysis from 2005-2014

Yuzhou Liu, MD, Hedong Han, MD, Xin Wei, MD, Qian Wang, MD MPH, Astha Thakkar, MBBS, Jia He, MD PhD

Blood (2017) 130 (Supplement 1): 3640.

https://doi.org/10.1182/blood.V130.Suppl_1.3640.3640

Published: 2017

Journal Articles

US Regional Difference in Hospitalization Cost for Autologous Stem Cell Transplantation in Multiple Myeloma Patients: A Nationwide 10-Year Analysis from 2005 to 2014

Yuzhou Liu, MD, Hedong Han, MD, Qian Wang, MD MPH, Astha Thakkar, MBBS, Xin Wei, MD, Jia He, MD PhD, Gabriel A Sara, MD

Blood (2017) 130 (Supplement 1): 4691.

https://doi.org/10.1182/blood.V130.Suppl_1.4691.4691

Published: 2017

Journal Articles

A Novel Gene Expression Classifier Enriches for Single Agent Clinical Activity of CC-122, a Cereblon Modulator, Administered Orally to Relapsed or Refractory Diffuse Large B-Cell Lymphoma Subjects: Results from the Phase I CC-122-ST-001 Study

Blood (2017) 130 (Supplement 1): 4118.

https://doi.org/10.1182/blood.V130.Suppl_1.4118.4118

Published: 2017

Journal Articles

CC-122 Expands Activated and Memory CD4 and CD8 T Cells In Vivo and Induces T Cell Activation Ex Vivo in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma and Multiple Myeloma

Blood (2015) 126 (23): 2704.

https://doi.org/10.1182/blood.V126.23.2704.2704

Published: 2015

Journal Articles

CC-122 Dosing on a Novel Intermittent Schedule Mitigates Neutropenia and Maintains Clinical Activity in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma

Cecilia Carpio, MD, Loïc Ysebaert, MDPhD, Raúl Cordoba, MD, Armando Santoro, MD, José Antonio López-Martín, MD, Juan Manuel Sancho, MD PhD, Carlos Panizo, PhD, Mecide Meric Gharibo, MD, Drew W Rasco, MD, Anne-Marie Stoppa, MD, Sylvia Damian, MD, Xin Wei, Patrick Hagner, PhD, Kristen Hege, Soraya Carrancio, PhD, Anita K. Gandhi, PhD, Michael Pourdehnad, MD, Vincent Ribrag, MD

Blood (2015) 126 (23): 1494.

https://doi.org/10.1182/blood.V126.23.1494.1494

Published: 2015

Journal Articles

CC-122 Degrades the Lymphoid Transcription Factor Aiolos (IKZF3) By Modulating Cereblon and Shows Clinical Activity in a Phase Ib Study of Subjects with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Multiple Myeloma

Vincent Ribrag, MD, Silvia Damien, MD, Mecide Gharibo, MD, Mercede Gironella, MD, Armando Santoro, MD, Drew W Rasco, MD, William Edenfield, MD, Xin Wei, PhD, Angela James, PhD, Patrick Hagner, PhD, Anita K. Gandhi, PhD, Rajesh Chopra, MD PhD, Jorge F. DiMartino, MD PhD, Michael Pourdehnad, MD, Anne-Marie Stoppa, MD

Blood (2014) 124 (21): 3500.

https://doi.org/10.1182/blood.V124.21.3500.3500

Published: 2014

NARROW

Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency

Leveraging gene expression subgroups to classify DLBCL patients and select for clinical benefit from a novel agent

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)

A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results

Costs and in-Hospital Mortality Rates in Autologous Stem Cell Transplant for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample (NIS) Database

Outcomes of Early Plasmapheresis Vs Late Plasmapheresis in Patients with Thrombocytopenic Thrombotic Purpura: A Nationwide Analysis from 2005-2014

US Regional Difference in Hospitalization Cost for Autologous Stem Cell Transplantation in Multiple Myeloma Patients: A Nationwide 10-Year Analysis from 2005 to 2014

A Novel Gene Expression Classifier Enriches for Single Agent Clinical Activity of CC-122, a Cereblon Modulator, Administered Orally to Relapsed or Refractory Diffuse Large B-Cell Lymphoma Subjects: Results from the Phase I CC-122-ST-001 Study

CC-122 Expands Activated and Memory CD4 and CD8 T Cells In Vivo and Induces T Cell Activation Ex Vivo in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma and Multiple Myeloma

CC-122 Dosing on a Novel Intermittent Schedule Mitigates Neutropenia and Maintains Clinical Activity in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma

CC-122 Degrades the Lymphoid Transcription Factor Aiolos (IKZF3) By Modulating Cereblon and Shows Clinical Activity in a Phase Ib Study of Subjects with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only